Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff

Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff

Abstract Background During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment. Methods As part of a study seeking to implement interim methadone without routine...

Full description

Bibliographic Details
Main Authors: Shannon Gwin Mitchell, Julia Jester, Jan Gryczynski, Melanie Whitter, Douglas Fuller, Caroline Halsted, Robert P. Schwartz
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Addiction Science & Clinical Practice
Subjects:
Methadone treatment
Opioid treatment programs
Regulations
COVID
Opioid use disorder treatment
Online Access:https://doi.org/10.1186/s13722-023-00417-7

Internet

https://doi.org/10.1186/s13722-023-00417-7

Similar Items